With foreign tourists boycotting the U.S., businesses brace for falling sales

With foreign tourists boycotting the U.S., businesses brace for falling sales


Key Points
  • International tourists are skipping trips to the U.S. amid tensions tied to trade, immigration and territory.
  • Many businesses that rely on foot traffic from overseas visitors are already seeing a financial hit, even before heading into peak travel season.
  • New York, Miami, Los Angeles, Orlando, San Francisco and Las Vegas are examples of cities with a large share of foreign visitors.



Source

Crypto theft is booming as criminals increasingly turn to physical attacks
Finance

Crypto theft is booming as criminals increasingly turn to physical attacks

Key Points So far this year, $2.17 billion has been stolen from crypto services — already eclipsing 2024’s amount, according to a report from Chainalysis. The total amount of crypto stolen from both platforms and individuals is nearing $3 billion amid a spike in attacks on individual crypto wallets. It comes as there have been […]

Read More
Stocks making the biggest premarket moves: PepsiCo, Starbucks, General Electric, Cars.com and more
Finance

Stocks making the biggest premarket moves: PepsiCo, Starbucks, General Electric, Cars.com and more

Check out the companies making the biggest moves in premarket trading: PepsiCo — The snack and beverage company rose 3% following its second-quarter beat on both the top and bottom lines. Adjusted earnings came in at $2.12 per share on revenues of $22.73 billion, versus the $2.30 per share on revenue of $22.28 billion, according […]

Read More
Stocks making the biggest moves after hours: United Airlines, Sarepta Therapeutics and more
Finance

Stocks making the biggest moves after hours: United Airlines, Sarepta Therapeutics and more

Check out the companies making headlines after the bell : United Airlines — Shares fell nearly 2% after the airline carrier posted a second-quarter revenue of $15.24 billion, missing analysts’ expectations of $15.35 billion, according to LSEG. Earnings, however, came in at $3.87 per share, exceeding the $3.81 consensus. Sarepta Therapeutics — The biopharma stock […]

Read More